News Medical on MSN2d
Scientists identify a new cancer immunotherapy target: Dysfunctional B cells
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...
GoodNewsNetwork2d
Teen with Rare Tumor Gets Marathon Facial Surgery Delivering Results in 7 Hours Instead of Several Years
Typically this would be spread out over a year, but thanks to advances in surgical precision and 3D printing, can be ...
A Timeline of Teddi Mellencamp’s Cancer Journey — and How Her Melanoma May Have Spread to Her Brain
After having 17 melanoma spots removed, ‘Real Housewives of Beverly Hills’ alum Teddi Mellencamp was diagnosed with multiple ...
Medical News Today10d
How diet affects cancer risk: What do recent studies say?
Recent studies show how dietary choices may affect a person's risk of cancer, particularly colorectal cancer, and cancer of ...
Cure Today1d
Ficerafusp Alfa Trial Begins for Recurrent/Metastatic Head and Neck Cancer
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.
Armed robbery in Revesby1d
Lancet: Drug Shows No Benefit for Head, Neck Cancer
A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and ...
Frontiers13d
Advancements in head and neck tumor treatment strategy driven by the perspective of precision oncology
Precision oncology is a cancer treatment approach that considers individual genetics, environmental exposures, and lifestyle factors to tailor the most ...
Dysfunctional B cells: A novel target for cancer immunotherapy and diagnostics
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...
EurekAlert!2d
Lancet article details drug’s lack of benefit for head and neck cancer
A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug ...